PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy

BACKGROUND: The prostate-specific membrane antigen (PSMA) is a relevant target in prostate cancer, and immunohistochemistry studies showed associations with outcome. PSMA-ligand positron emission tomography (PET) is increasingly used for primary prostate cancer staging, and the molecular imaging TNM...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hui, Amiel, Thomas, Würnschimmel, Christoph, Langbein, Thomas, Steiger, Katja, Rauscher, Isabel, Horn, Thomas, Maurer, Tobias, Weber, Wolfgang, Wester, Hans-Juergen, Knorr, Karina, Eiber, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380207/
https://www.ncbi.nlm.nih.gov/pubmed/34417907
http://dx.doi.org/10.1186/s13550-021-00818-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380207/
https://www.ncbi.nlm.nih.gov/pubmed/34417907
http://dx.doi.org/10.1186/s13550-021-00818-2

Ejemplares similares